Track how companies discuss tariffs and trade policies in their earnings calls, and understand their impact across different industries and regions.
Gross margin for the quarter was 58.3%, and adjusted operating margin was 29.1%, reflecting the impact of regional sales mix and margin dilution from tariff surcharges.
Our exposure to tariffs is negligible across our operations. And importantly, Canadian oil and gas delivered to the U.S. via our systems has not attracted tariffs.
The macro environment has been volatile and uncertain with tariff policies changing frequently.
deployment environment was modestly impacted, particularly at the beginning of the quarter...as the markets adjusted for the impact of new tariff policies.
we do not currently expect a 15% tariff on non-generic pharmaceutical products to have a material impact on our financial results in 2025.
these results do reflect our estimate of tariff-related LIFO inventory valuation headwinds.
my initial reaction is what we're going to do is see trade flows maybe change, but ultimately, the world is round and there's still a level of demand that has to be met
We do not, however, expect that this will necessarily continue in Q3 and Q4 as it depends on how and when the U.S. tariffs and potential retaliations will impact our industry.
the cost environment is difficult as we're dealing with tariff increases, higher raw and packaging material costs
During the second quarter, the North American polyolefins industry experienced volatility as markets adapted to an evolving tariff landscape.